Principal Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.91M Sell
4,601,441
-92,681
-2% -$159K ﹤0.01% 1375
2025
Q1
$15.6M Buy
4,694,122
+1,047,335
+29% +$3.49M 0.01% 997
2024
Q4
$27M Sell
3,646,787
-386,397
-10% -$2.86M 0.01% 695
2024
Q3
$37.9M Buy
4,033,184
+1,496,941
+59% +$14.1M 0.02% 557
2024
Q2
$20.3M Buy
2,536,243
+530,338
+26% +$4.25M 0.01% 843
2024
Q1
$29.7M Sell
2,005,905
-630,422
-24% -$9.34M 0.02% 684
2023
Q4
$21.4M Sell
2,636,327
-6,828
-0.3% -$55.5K 0.01% 828
2023
Q3
$12M Buy
2,643,155
+772,905
+41% +$3.52M 0.01% 1119
2023
Q2
$13.2M Sell
1,870,250
-42,522
-2% -$299K 0.01% 1103
2023
Q1
$11.7M Buy
1,912,772
+881,181
+85% +$5.38M 0.01% 1180
2022
Q4
$6.59M Sell
1,031,591
-35,841
-3% -$229K 0.01% 1441
2022
Q3
$10.2M Buy
1,067,432
+150,749
+16% +$1.44M 0.01% 1180
2022
Q2
$10.1M Buy
916,683
+350,025
+62% +$3.86M 0.01% 1247
2022
Q1
$9.44M Buy
566,658
+5,071
+0.9% +$84.4K 0.01% 1406
2021
Q4
$10.7M Buy
561,587
+14,720
+3% +$281K 0.01% 1349
2021
Q3
$13.5M Buy
546,867
+21,784
+4% +$537K 0.01% 1240
2021
Q2
$13.7M Buy
525,083
+106,211
+25% +$2.76M 0.01% 1254
2021
Q1
$13.3M Buy
418,872
+37,419
+10% +$1.18M 0.01% 1233
2020
Q4
$17.7M Buy
381,453
+10,779
+3% +$500K 0.01% 856
2020
Q3
$12.2M Buy
370,674
+806
+0.2% +$26.5K 0.01% 946
2020
Q2
$10.2M Buy
369,868
+178,760
+94% +$4.91M 0.01% 1048
2020
Q1
$5.72M Buy
191,108
+88,858
+87% +$2.66M 0.01% 1218
2019
Q4
$2.83M Buy
102,250
+65,635
+179% +$1.82M ﹤0.01% 1664
2019
Q3
$666K Buy
36,615
+3,303
+10% +$60.1K ﹤0.01% 1892
2019
Q2
$817K Buy
33,312
+4,095
+14% +$100K ﹤0.01% 1870
2019
Q1
$278K Buy
29,217
+4,320
+17% +$41.1K ﹤0.01% 2055
2018
Q4
$220K Sell
24,897
-4,337
-15% -$38.3K ﹤0.01% 2107
2018
Q3
$329K Buy
29,234
+4,108
+16% +$46.2K ﹤0.01% 2057
2018
Q2
$322K Buy
+25,126
New +$322K ﹤0.01% 2063
2017
Q2
Sell
-10,172
Closed -$76K 2273
2017
Q1
$76K Hold
10,172
﹤0.01% 2160
2016
Q4
$71K Buy
+10,172
New +$71K ﹤0.01% 2179
2015
Q3
Sell
-12,391
Closed -$114K 2201
2015
Q2
$114K Buy
+12,391
New +$114K ﹤0.01% 2119